3

OWNERSHIP DOCUMENT

Company: Kyverna Therapeutics, Inc.
Filed: February 7, 2024
Period of Report: February 7, 2024
Accession Number: 0001104659-24-011799

View Document ↗ View on SEC.gov ↗